Correction: Drug Safety 10.1007/s40264-025-01641-7.
In this article, the conflict of interest statement was incorrectly published. The correct statement is given below:
Conflict of interest AKR reports membership on a data safety monitoring board (DSMB) for matters unrelated to the presented research. SGS reports consulting for Astra-Zeneca, GSK, Sanofi, Pfizer, Moderna, CSL Seqirus, Novavax, and Evo Health on work unrelated to the presented research. FMM has been an investigator in pediatric studies of coronavirus disease 2019 vaccines for Pfizer and Moderna, and for a pediatric remdesivir study conducted by Gilead Sciences; is an investigator on projects supported by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC); has served as a member of the DSMB for clinical trials conducted by Pfizer, Dynavax, Moderna, Meissa Vaccines, Virometix, and the NIH; and has served as a consultant to Merck, Moderna, Sanofi, Astra Zeneca, and GSK. SLR reports consulting for CSL Seqirus on work unrelated to the presented research. All other authors report no potential conflicts.
The original article has been corrected.